{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:43:50Z","timestamp":1791607430881,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703149"],"award-info":[{"award-number":["81703149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602784"],"award-info":[{"award-number":["81602784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502709"],"award-info":[{"award-number":["81502709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.biopha.2019.109181","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T23:26:23Z","timestamp":1562282783000},"page":"109181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea"],"prefix":"10.1016","volume":"117","author":[{"given":"Xin","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"May (5)","key":"10.1016\/j.biopha.2019.109181_bib0005","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea: part I. Introduction, categorization, histology, pathogenesis,and risk factors","volume":"72","author":"Two","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"uly","key":"10.1016\/j.biopha.2019.109181_bib0010","doi-asserted-by":"crossref","first-page":"e3527","DOI":"10.7717\/peerj.3527","article-title":"An observational descriptive survey of rosacea in the Chinese population: clinical features based on the affected locations","volume":"5","author":"Xie","year":"2017","journal-title":"Peerj"},{"issue":"November (18)","key":"10.1016\/j.biopha.2019.109181_bib0015","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMcp1506630","article-title":"Rosacea","volume":"377","author":"van Zuuren","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"February (2)","key":"10.1016\/j.biopha.2019.109181_bib0020","article-title":"The Rosacea-specific Quality-of-Life instrument (RosQol): revision and validation among Chinese patients","volume":"13","author":"Deng","year":"2018","journal-title":"PLoS One"},{"issue":"December","key":"10.1016\/j.biopha.2019.109181_bib0025","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jaad.2013.04.045","article-title":"NEw insights into rosacea pathophysiology: a review of recent findings","volume":"69","author":"Steinhoff","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"issue":"November-December (6)","key":"10.1016\/j.biopha.2019.109181_bib0030","first-page":"1344","article-title":"Clinical characteristics and epidermal barrier function of papulopustular rosacea: a comparison study with acne vulgaris","volume":"32","author":"Zhou","year":"2016","journal-title":"Pak. J. Med. Sci."},{"issue":"March (3)","key":"10.1016\/j.biopha.2019.109181_bib0035","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"August (8)","key":"10.1016\/j.biopha.2019.109181_bib0040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2019.109181_bib0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jidsymp.2011.9","article-title":"Rosacea: The cytokine and chemokine network","volume":"15","author":"Gerber","year":"2011","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"issue":"December (1)","key":"10.1016\/j.biopha.2019.109181_bib0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"issue":"September (9)","key":"10.1016\/j.biopha.2019.109181_bib0055","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in Rosacea Reveals activation of Th1\/Th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"December (1)","key":"10.1016\/j.biopha.2019.109181_bib0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","article-title":"Neurovascular and neuroimmune aspects in the pathophysiology of rosacea","volume":"15","author":"Schwab","year":"2011","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"issue":"5","key":"10.1016\/j.biopha.2019.109181_bib0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/11537020-000000000-00000","article-title":"Rosacea treatments: what\u2019s new and what\u2019s on the horizon","volume":"11","author":"Gallo","year":"2010","journal-title":"Am. J. Clin. Dermatol."},{"issue":"November (5)","key":"10.1016\/j.biopha.2019.109181_bib0070","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2005.04.069","article-title":"A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea","volume":"53","author":"Sanchez","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"issue":"May (5)","key":"10.1016\/j.biopha.2019.109181_bib0075","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Del Rosso","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"issue":"January (1)","key":"10.1016\/j.biopha.2019.109181_bib0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-4362.1993.tb00974.x","article-title":"Treatment of rosacea: topical clindamycin versus oral tetracycline","volume":"32","author":"Wilkin","year":"1993","journal-title":"Int. J. Dermatol."},{"issue":"June (6)","key":"10.1016\/j.biopha.2019.109181_bib0085","first-page":"650","article-title":"Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies","volume":"12","author":"Jr","year":"2013","journal-title":"J. Drugs Dermatol."},{"issue":"December (22)","key":"10.1016\/j.biopha.2019.109181_bib0090","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1001\/jama.2015.15287","article-title":"Interventions for rosacea","volume":"314","author":"van Zuuren","year":"2015","journal-title":"JAMA"},{"issue":"May (4703)","key":"10.1016\/j.biopha.2019.109181_bib0095","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"issue":"January","key":"10.1016\/j.biopha.2019.109181_bib0100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-med-043015-123453","article-title":"Antimalarial drugs as immune modulators: new mechanisms for old drugs","volume":"68","author":"An","year":"2017","journal-title":"Annu. Rev. Med."},{"issue":"September (3)","key":"10.1016\/j.biopha.2019.109181_bib0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1043-6618(03)00107-5","article-title":"Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro","volume":"48","author":"Chen","year":"2003","journal-title":"Pharmacol. Res."},{"issue":"February","key":"10.1016\/j.biopha.2019.109181_bib0110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.intimp.2018.12.031","article-title":"Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis","volume":"67","author":"Li","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"June (6)","key":"10.1016\/j.biopha.2019.109181_bib0115","first-page":"8385","article-title":"The therapeutic effect of artesunate on rosacea through the inhibition of the JAK\/STAT signaling pathway","volume":"17","author":"Li","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"May (5)","key":"10.1016\/j.biopha.2019.109181_bib0120","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3892\/etm.2013.988","article-title":"Saikosaponin A mediates the inflammatory response by inhibiting the MAPK and NF-\u03baB pathways in LPS-stimulated RAW 264.7 cells","volume":"5","author":"Zhu","year":"2013","journal-title":"Exp. Ther. Med."},{"issue":"May","key":"10.1016\/j.biopha.2019.109181_bib0125","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.12659\/MSM.905580","article-title":"Brain natriuretic peptide-regulated expression of inflammatory cytokines in lipopolysaccharide (LPS)-Activated macrophages via NF-kB and mitogen activated protein kinase (MAPK) pathways","volume":"24","author":"Li","year":"2018","journal-title":"Med. Sci. Monit."},{"issue":"12","key":"10.1016\/j.biopha.2019.109181_bib0130","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/exd.12030","article-title":"Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation","volume":"21","author":"Casas","year":"2012","journal-title":"Exp. Dermatol."},{"issue":"January (1)","key":"10.1016\/j.biopha.2019.109181_bib0135","article-title":"TLR2\/MyD88\/NF-\u03baB pathway, reactive oxygen species, potassium efflux activates NLRP3\/ASC inflammasome during respiratory syncytial virus infection","volume":"7","author":"Segovia","year":"2012","journal-title":"PLoS One"},{"issue":"November (9)","key":"10.1016\/j.biopha.2019.109181_bib0140","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.4049\/jimmunol.179.9.5958","article-title":"Anti-inflammatory properties and regulatory mechanism of a novel derivative of artemisinin in experimental autoimmune encephalomyelitis","volume":"179","author":"Wang","year":"2007","journal-title":"J. Immunol."},{"issue":"November (6)","key":"10.1016\/j.biopha.2019.109181_bib0145","doi-asserted-by":"crossref","first-page":"38115","DOI":"10.1038\/srep38115","article-title":"Artemisinin analogue SM934 attenuate collagen-induced arthritis by suppressing T follicular helper cells and T helper 17 cells","volume":"29","author":"Lin","year":"2016","journal-title":"Sci. Rep."},{"issue":"October (10)","key":"10.1016\/j.biopha.2019.109181_bib0150","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ni.2680","article-title":"The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells","volume":"14","author":"Heath","year":"2013","journal-title":"Nat. Immunol."},{"issue":"July (1)","key":"10.1016\/j.biopha.2019.109181_bib0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.immuni.2016.06.021","article-title":"Antimicrobial peptide LL37 and MAVS signaling drive interferon-beta production by epidermal keratinocytes during skin injury","volume":"45","author":"Zhang","year":"2016","journal-title":"Immunity"},{"issue":"October (10)","key":"10.1016\/j.biopha.2019.109181_bib0160","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/aps.2017.185","article-title":"Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages","volume":"39","author":"Yan","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"October","key":"10.1016\/j.biopha.2019.109181_bib0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"December (12)","key":"10.1016\/j.biopha.2019.109181_bib0170","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1515\/BC.2009.144","article-title":"Chemokines in tumor-associated angiogenesis","volume":"390","author":"Gerber","year":"2009","journal-title":"Biol. Chem."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219310339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219310339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:37:51Z","timestamp":1777574271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219310339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":34,"alternative-id":["S0753332219310339"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109181","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109181"}}